1. Pink Sheet

Endo And Allergan Could Edge Out Of Opioid Bellwether Trial Spotlight With Proposed Settlements

 
• By Brenda Sandburg

Companies reach agreements in principal with plaintiffs in bellwether trial in the US multidistrict litigation as court date nears; plaintiffs narrow their claims from 11 to seven.

Gavel-money

Endo International PLC and Allergan PLC's proposed settlements with the two Ohio county plaintiffs in the upcoming trial in the massive US multidistrict opioid litigation give them some reprieve from the high-profile proceedings as the parties continue to discuss a comprehensive resolution of the litigation.

The two Ohio counties are the plaintiffs in the multidistrict litigation (MDL) "bellwether trial," in which a representative case is tried first to test the parties' arguments and provide a basis for addressing the remaining cases and a potential settlement

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 
• By Sue Sutter and Derrick Gingery

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.